September 18th 2024
Your daily dose of the clinical news you may have missed.
September 17th 2024
New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.
September 13th 2024
Unawareness was highest among the youngest adults, aged 18 to 44 years, an age range where CV health should be optimized to avoid later morbidity, researchers wrote.
Approximately 10.5 million US adults, or 5% of the population, have the atrial fibrillation, according to new prevalence estimates.
September 12th 2024
Elevated Urinary Stress Hormones Up Risk for Hypertension, CV Events in Prospective Cohort Study
Each doubling of levels of 4 stress hormones was associated with a 21-31% increase in risk of developing hypertension over a median 6.5-year follow-up.
Study: Younger Cannabis Users Nearly Twice as Likely to Report Heart Attack
New research suggests frequent cannabis use can raise the risk of myocardial infarction in adults younger than 45 years.
HIV Infection Linked to Elevated Risk for Sudden Cardiac Death in Veterans, New Study Shows
Patients with HIV had a 14% higher risk of sudden cardiac death than those without HIV, according to a large analysis of US veterans.
ESC 2021: Flu Vaccine Cuts Risk of Death, Heart Attack in Patients with Heart Disease
ESC Congress 2021: Results from the largest trial of its kind suggest that flu vaccination should be part of in-hospital treatment after myocardial infarction.
ESC 2021: Major Hypertension Trial Supports Tight BP Control with Data from Older Adults
Aggressive control of systolic BP in adults aged 60 to 80 years significantly reduced CV risk, adding to evidence from the pivotal SPRINT trial in support of tight BP control.
ESC 2021: Low-sodium Salt Alternative Found to Reduce Risk of Stroke
Substituting regular salt with low-sodium alternative was found to reduce the risk of stroke, major cardiovascular events, and death in a new study presented at ESC Congress 2021.
ESC 2021: Empagliflozin Found Beneficial in Patients with Heart Failure Regardless of Ejection Fraction
In a pooled analysis of 2 key clinical trials, empagliflozin was beneficial in patients with heart failure with a reduced and preserved ejection fraction.
New Study Suggests Link Between Saturated Fat and CVD Risk Varies by Food Source
Consuming saturated fat from meat may be associated with a higher risk of CVD than other food sources, according to a new study presented at ESC Congress 2021.
ESC 2021: Patients with Prior Myocardial Infarction and Gum Disease Face Higher Risk of Heart Disease
Periodontitis was associated with an increased risk for CVD, particularly among patients with past myocardial infarction, in a new study being presented at ESC Congress 2021.
ESC 2021: Despite Smoking Less, Women Find it Harder to Quit Than Men
New findings being presented at ESC Congress 2021 highlight the need for smoking cessation services tailored to the specific needs of women.
Rivaroxaban: New Indication for Use in PAD Following Lower Extremity Revascularization
With the post-LER PAD indication, rivaroxaban becomes the only anticoagulant in 2 decades to demonstrate safety and efficacy in the high-risk population.
ESC 2021: The Risk of Young-onset Heart Attack May Go Beyond Family History
Younger adults with myocardial infarction are more likely to be smokers, obese, and have hypertension than their peers, suggests a new study being presented at the ESC Congress 2021.
Moderate Exercise Found to Lower All-cause Mortality After Stroke, Particularly in Younger Patients
A new study suggests that walking even 3 or 4 hours a week may reduce long-term mortality from any cause in patients with a history of stroke.
Moderate Alcohol Intake Associated with Lower Risk of CV Death, Events in Adults with CVD
A recent meta-analysis found that consuming up to 105 g of alcohol a week was associated with lower risks of cardiovascular events and mortality among adults with CVD.
8 Questions on Diabetes Drugs for Cardioprotection
Take this quick quiz to test your knowledge of key findings in landmark studies on the cardioprotective effects of SGLT2i and GLP-1 RAs.
A Plant-based Diet May Decrease Risk of CVD in Young Adults, Older Women
Eating a more plant-centered diet was associated with lower risk for CVD among both young adults and postmenopausal women, according to two new studies.
Diabetes Drugs and Cardioprotection: A Summary for Primary Care
These concise summaries highlight the latest findings on the cardioprotective effects of SGLT2 inhibitors and GLP-1 RA in patients with diabetes.
Role of Primary Care in Poststroke Care: 6 Takeaways from New AHA/ASA Scientific Statement
In a new scientific statement, the AHA/ASA recommends that the first poststroke visit should occur earlier in primary care. Details plus 5 more key points primary care physicians should know.
New Study Casts More Doubt on Negative Link Between Coffee Intake and Risk of Arrhythmia
Regular coffee consumption was associated with a 3% lower risk of incident arrhythmia, a large study of UK adults found.
Mental Health & Cardiovascular Disease: What's the Link?
What does the latest research say about the association between mental health and cardiovascular disease? Scroll through our quick slideshow for an overview.
Study: Statins Reduce CVD, Mortality in Low-risk Patients with Type 2 Diabetes
A recent study found that the use of statins in patients with newly diagnosed T2D reduced incidence of cardiovascular disease and death, particularly among older patients.
Study: No Link Found between Statin Use and Cognitive Decline, Dementia in Older Adults
A new analysis of the large ASPREE trial found statin use in older adults is not associated in the incidence of dementia or a decline in neurocognitive health.
CDC Reschedules Meeting on Reports of Myocarditis Following COVID-19 Vaccination
The special meeting to review cases of myocarditis in the US following COVID-19 vaccination, will now take place this Wednesday during the ACIP online meeting.
Despite Knowing the Risks, Many Adults with CVD Report Current Tobacco Use
Although over 90% of adults with a history of CVD reported knowing that smoking can cause heart disease, nearly 30% reported current tobacco use in a new study.
Study Shows Benefits of Bariatric Surgery for Mild-to-Moderate Obesity
A new study challenges traditional criteria for patient selection for metabolic surgery, demonstrating significant weight loss and disease remission for those with BMI of 30-35.
ACC.21: High- and Low-Dose Aspirin Both Effective for Patients with Established Cardiovascular Disease
ACC.21: There was no difference found between high- and low-dose aspirin in terms of effectiveness and safety in patients with established CVD, according to new research.
AHA Statement on Obesity and CVD: 10 Key Points, to Start
The links between obesity and cardiovascular disease are many, including direct cause and effect. Click through the 10-slide summary of a new AHA statement for a first look.
Atypical Symptoms of Heart Attack Associated with 3-fold Higher Mortality Rate, New Study Finds
Atypical symptoms were most common among older patients with myocardial infarction, especially women, who called a non-emergency helpline for assistance, study authors found.
ACP: ASCVD Risk Estimation for Primary Prevention with Donald Lloyd-Jones, MD, ScM
"Risk estimators do not prescribe a drug," says Dr Lloyd-Jones. They are tools to help make the decision to prescribe the drug. He explains how to use them in primary care.
ACP: Clyde Yancy, MD, MSc Reviews Advances in Heart Failure Research and Treatment
ACP: Clyde W Yancy, MD, gave a comprehensive update on a year's worth of pivotal science in treatment of heart failure. Here are the highlights.